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Abstract
Background: Evidence suggests an inverse relationship between soy protein intake and serum
concentrations of male sex hormones. Anecdotal evidence indicates that these alterations in serum
sex hormones may attenuate changes in lean body mass following resistance training. However,
little empirical data exists regarding the effects of soy and milk-based proteins on circulating
androgens and exercise induced body composition changes.
Methods: For 12 weeks 20 subjects were supplemented with 50 g per day of one of four different
protein sources (Soy concentrate; Soy isolate; Soy isolate and whey blend, and Whey blend only)
in combination with a resistance-training program. Body composition, testosterone, estradiol and
sex hormone binding globulin (SHBG) were measured at baseline and week 12.
Results: Protein supplementation resulted in a significant increase in lean body mass independent
of protein source (0.5 ± 1.1 and 0.9 ± 1.4 kg, p = 0.006, p = 0.007). No significant differences were
observed between groups for total and free testosterone, SHBG, percentage body fat, BMI or body
weight. The Testosterone/Estradiol ratio increased across all groups (+13.4, p  = 0.005) and
estradiol decreased (p  = 0.002). Within group analysis showed significant increases in the
Testosterone/Estradiol ratio in soy isolate + whey blend group (+16.3, p = 0.030). Estradiol was
significantly lower in the whey blend group (-9.1 ± 8.7 pg/ml, p = 0.033).
Conclusion: This investigation shows that 12 week supplementation with soy protein does not
decrease serum testosterone or inhibit lean body mass changes in subjects engaged in a resistance
exercise program.
Background
The maintenance of skeletal muscle mass can be defined
as the net result of protein synthesis and degradation. In
most healthy persons the consumption of regular meals
without training results in a relatively stable balance of
muscle tissue over time. Generally it is acknowledged that
a combination of training and adequate nutrition pro-
motes the accretion of lean body tissue; the presence of a
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training stimulus and a positive protein balance fosters
skeletal muscle fiber hypertrophy [1,2].
An aspect of adequate nutritional intake is related to the
bioavailability of ingested dietary protein and its source
(i.e. essential amino acids) which can directly influence
the magnitude of adaptation of a given training stimulus.
Previous work has suggested that soy protein is preferen-
tially directed towards the splanchnic region and milk
proteins, (i.e. whey and casein), to peripheral regions
such as muscle tissues [3,4]. When compared to soy pro-
teins, milk proteins provide greater amounts of the
branched chain amino acids (BCAAs) leucine, isoleucine
and valine, as well as methionine and lysine [5-8]. Recent
work has identified the importance of the BCAA leucine in
the activation of myogenic translation initiation factors
such as MTOR, P70 S6 kinase and eIF4E – eIF4G [for
review see: [9-11]], which are considered important for
muscle hypertrophy. As such the relatively low BCAA con-
tent found in soy protein may decrease the effectiveness of
downstream leucine signaling [5].
Phytoestrogens (isoflavones) are a group of natural estro-
gen receptor modulators that are highly concentrated in
soy foods, including soy protein isolates [12]. Soy isofla-
vones have comparable molecular weights and are struc-
turally similar to 17-beta estradiol, which may enable
them to exert estrogenic and antiestrogenic activities
through their associated receptor-binding site [13]. In-
vitro studies lend support to this relationship by demon-
strating the ability of soy to inhibit a variety of androgenic
and estrogenic hormones including: testosterone [14], sex
hormone binding globulin (SHBG) [15], esterone [16]
and testosterone/estradiol ratio [17]. However, in-vivo
evidence shows that the source and concentration of soy
isoflavones does not impact levels of circulating sex hor-
mones [18-20]. It has been demonstrated circulating sex
hormone levels are closely linked to the adaptive response
to resistance exercise [21]. This provides one such premise
regarding the perception that soy protein sources are infe-
rior to milk proteins such as whey for supporting lean
mass accretion in males engaged in resistance exercise
[22].
Although there is some evidence regarding the benefits of
whey over soy as an efficient adaptogenic protein source
for muscle tissue, no human studies have compared the
two proteins directly in response to resistance training.
Based on this background, the present study assessed the
effect of 12 weeks of resistance training and dietary sup-
plementation with soy, whey or a combination, on body
composition and plasma sex hormone concentrations.
Methods
Subjects and study design
Forty-one potential subjects were recruited from the local
community and screened using a brief phone call and
questionnaire. If the initial screening led to selection as a
potential candidate for inclusion, renal and liver function
tests were performed. Inclusion criteria included healthy
males 18 – 40 years of age with a BMI of < 40 kg/m2.
Exclusion criteria included the following: (a) Self pro-
fessed vegetarians, or followers of ketogenic or carbohy-
drate restrictive diets, (b) Supplemental creatine users, (c)
Subjects with renal and liver function test higher than 1.5
– 2 × normal, (d) Subjects that had used anabolic steroids
within the last year and/or were using stimulants over the
past 90 days, (e) Subjects who had experienced weight
loss or gain greater than 4.5 kg over the previous 90 days.
Twenty young healthy men (age, 30.7 ± 6.5 years; height,
176.3 ± 7.7 cm; weight, 82.0 ± 12.3 kg; mean ± SD) com-
pleted the 12 week study. All aspects of the investigation
were first approved by the Ethics Review Committee of
IntegReview (Austin, TX). Subjects were informed of exper-
imental procedures and signed informed consent state-
ments according to human subject guidelines of the
Declaration of Helsinki, The US-FDA guidelines and those
of IntegReview. The subjects were matched according to
training experience, experienced (greater than 3 months)
and inexperienced (less than 3 months), and randomly
assigned to either soy isolate, soy concentrate, whey
blend, or soy isolate plus whey blend group. Subject char-
acteristics are outlined in Table 1. To maintain study and
Table 1: Subject characteristics at pre-training
Group 1 (SI) n = 5 Group 2 (SC) n = 5 Group 3 (WB) n = 5 Group 4 (SW) n = 5
Age (y) 30.3 ± 8.1 31.6 ± 5.9 31.4 ± 5.1 29.6 ± 7.0
Weight (kg) 82.1 ± 20.3 86.1 ± 6.9 80.9 ± 8.7 78.7 ± 13.3
Height (cm) 175.8 ± 13.7 172.1 ± 8.5 177.6 ± 5.2 179.8 ± 3.5
BMI (kg/m2) 28.2 ± 6.1 29.2 ± 3.7 26.4 ± 3.0 24.4 ± 4.6
Testtot (ng/dl) 522 ± 69.4 649.6 ± 205.3 609.3 ± 164.9 522.4 ± 188.1
Testfree (pg/ml) 101.1 ± 11.9 146.7 ± 38.4 128.2 ± 47.7 101.4 ± 21.4
Estradiol (pg/ml) 21.7 ± 6.8 24.2 ± 2.3 27.1 ± 8.6 20.0 ± 4.1
SHBG (nM/l) 24.3 ± 11.2 23.2 ± 7.1 21.3 ± 21.1 29.4 ± 14.2
Testfree/Estradiol ratio 25.3 ± 5.7 26.9 ± 8.2 25.0 ± 10.7 26.5 ± 9.7
Data are mean ± SD. No significant pre-training group differences were found (p < 0.05) n = 20Journal of the International Society of Sports Nutrition 2007, 4:4 http://www.jissn.com/content/4/1/4
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subject blinding, neither researchers nor subjects knew
which group they belonged to until completion of the
trial and laboratory analysis. Safety (clinical blood analy-
sis, adverse event [AE] records) and efficacy end points
(body weight and composition change) were assessed at
baseline and end-of-study (week 12).
Supplementation
Subjects had diets supplemented with four study protein
powders: soy protein isolate (SI), soy concentrate (SC),
whey blend (50% whey concentrate, 50% whey isolate)
(WB) or a 50:50 mixture of soy isolate and whey blend
(SW). Study treatment powders were analyzed in dupli-
cate by HPLC for nutritional composition including iso-
flavone content (Nestle Purina Analytical Labs, St Louis,
USA). Soy protein was supplied by the Solae Company,
LLC and whey proteins from Land O'Lakes, Inc. Batch
sample analyses are outlined in Table 2. On training days,
subjects were instructed to dissolve one serving (25 g) of
protein supplement in 10–12 oz of water and ingest
within 1 h following training; a second dose was con-
sumed later in the day. On non-training days subjects con-
sumed two doses of protein at different times throughout
the day. Product compliance was assessed upon weekly
returns of empty packets to the laboratory. Packaging and
taste were masked to disguise identification of the protein
supplements.
Training and mood profiling
Weight training was performed 3 days per week for 12
weeks with individual instruction once per week by a
qualified personal trainer to ensure maintenance of ade-
quate intensity, training load, and correct form were fol-
lowed as per protocol. Program design was in accordance
with and based on the American College of Sports Medi-
cine recommendations for hypertrophy [23]. The hyper-
trophic training protocol consisted of 3–4 sets of 8–12
repetitions per set and 1–2 minutes rest between sets. The
following exercises were performed to emphasize multi-
joint exercise for large then smaller muscle groups, respec-
tively: 1) Bench press; 2) Military press; 3) Bicep curls; 4)
Tricep pushdowns 5) Leg press or Squat; 6) Supine leg
curls; 7) Leg extensions; 8) Calf rises and 9) Abdominal
crunches. It was recommend that subjects rest for 48 h
between training the same body-part to allow for ade-
quate recovery. Profile of mood states for fatigue and vigor
(POMS-F/V) [15] were recorded at baseline and week 12.
Biochemical body composition analyses
Following an overnight fast blood samples were obtained
pre study (screen) and weeks 0 (baseline), and 12 for each
intervention group. Blood samples were also collected at
week 6 to assess patients metabolic panel including CBC
w/differential as part of study safety protocol. Subjects
were requested to refrain from food and beverages (except
water) for 12 h prior to each blood draw. Blood was
drawn from the antecubital vein into anti-coagulant free
tubes centrifuged at 1200 × g at 4°C and serum removed
within 5 min of separation. Serum aliquots were then
divided and stored at -80°C until analysis. Serum samples
underwent duplicate analysis for complete the metabolic
panel and CBC w/differential, androgens, estrogens, and
SHBG (Quest Diagnostics, Miramar, Florida). Serum total
and free testosterone were analyzed using Liquid chroma-
tography mass spectrometry (LC/MS) at a commercial
laboratory (Quest Diagnostics, Miramar, FL.). SHBG and
estradiol were analyzed using an immunoradiometric
assay with I-labeled antibodies. Intra- and inter-assay var-
iability was 8.3% and 8.6% for Testfree, 9.4% and 11.7%
for TestTot, 7.2% and 9.46% for estradiol, respectively.
Body composition was determined  at weeks 0 and 12 by
Dual-Energy X-Ray Absorptiometry (DEXA; Hologic QDR
4500W v 11.2).
Food recording
Each subject received detailed instruction before complet-
ing a multiple pass 24 h dietary recall at baseline and post
interventions [24]. Subjects were encouraged to provide as
much detail as possible including submission of food
labels and recipes. Food records were analyzed using
Nutritionist Pro™ Ver. 1.1 (Hearst Corporation, CA) and
for each 24 h dietary recall, mean and SD intakes of energy
and macronutrients were calculated [24].
Statistical analysis
Treatment effects were assessed by comparing the amount
of change from baseline to end-of-study among the four
formulation groups by a one-way, four-level factorial
analysis of variance (ANOVA) with Tukey HSD post-hoc
Table 2: Composition of supplements used in experimental 
interventions
Active Compound SI SC SW WB
Protein (%) 59 59.5 59.5 60
Calcium# 304 418 379 438
Ash (%) 5.1 6.7 5.3 5.5
Fat, acid hydrolysis (%) 2.3 2.6 1.8 2.7
Moisture (%) 3.6 3.2 3.5 3.6
Phosphorus# 626 813 481 295
Potassium# 1450 1540 1530 1410
Sodium# 491 539 536 574
Genistein-containing compounds# 62 49 30 10
Daidzein-containing compounds# 29 107 14 2
Glycitein-scontaining compounds# 7 20 4.0 0
Genistein# 37 83 18 1.0
Daidzein# 17 59 8 1.0
Glycitein# 4 12 2.0 0
Total aglycone Components# 58 154 29 2
Total isoflavones# 98 276 48 3
Mean data values
# Concentration = mg/100 gJournal of the International Society of Sports Nutrition 2007, 4:4 http://www.jissn.com/content/4/1/4
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tests. Changes over time from baseline to each subsequent
visit within each formulation group were assessed for sig-
nificance by the one-sample Students t-test (testing
whether the change from baseline was significantly differ-
ent from zero). Analysis (per protocol, finishers only)
were undertaken on only 20 of the initial 41 subjects were
full data collection, product compliance greater than
50%, and all laboratory and training sessions attended.
Where appropriate, Fisher's Exact test was utilized for
comparison of event rates. The sample size for this pilot
study was predetermined, and not obtained by a formal
power calculation. Thus no formal pre-study power anal-
ysis was undertaken and the data is considered inferential
and not conclusive. Statistical analyses (descriptive statis-
tics and Students t-tests) were performed using SPSS
ver.11.5 (SPSS Inc., Chicago IL). The Fisher's Exact test,
and the analysis of the alpha and power characteristics of
the hybrid study design, were performed using R ver.1.9.1.
An alpha level of p < 0.05 was considered significant.
Results
Subject characteristics
Subject (n = 20) characteristics taken at baseline are given
in Table 1. A significant increase in all groups in lean body
mass was present (0.9 kg, p = 0.007) however following a
within group analysis a trend towards significance for an
increase in lean body mass was present only in the SI
group (p = 0.055) (Figure 1). During the study, BMI and
body weight increased but not significantly and percent-
age body fat did not change. No important adverse events
occurred that were likely related to the use of the protein
supplements and as such no significant AE rates were
reported across the four formulation groups. Some iso-
lated changes in metabolic panel and CBC w/differential
were noted although not clinically important as defined
within the normal clinical range, or consistently occurring
across supplemental groups when assessed at baseline,
midpoint or week 12.
Dietary intakes
The intakes of energy and macronutrients based on 24 h
dietary recall showed significant differences among the
formulations for kcals and fat, respectively (-555 ± 1029;
p = 0.026; -27 ± 41 g/day, p = 0.009). A comparison of
food records over the 12-week study period revealed that
subjects consumed significantly more protein (+63 g/day,
p = 0.013) in the SC group at baseline compared to week
12 (Table 3).
Serum sex hormones and SHBG
Over the study period serum measurements of free and
total testosterone did not differ significantly between or
within groups (Figures 2 and 3). However, a significant
increase was noted in the testosterone/estradiol ratio
across groups (+13.4, p = 0.005). Specifically, the testo-
sterone/estradiol ratio in the SW group was higher at week
12 in comparison to baseline measurements (+16.3, p =
0.030) (Figure 4). The effects of supplementation on
SHBG within and across all groups were not statistically
significant (Figure 5).
Table 3: Changes in baseline versus end study dietary analysis following PPA
SC SI SW WB Total p
Caloric Intake 
Kcals/day
141 ± 386 p = 0.461 -465 ± 494 p = 0.244 -1558 ± 1298 p = 0.055 -373 ± 875 p = 0.302 -555 ± 1029 p = 0.026 0.047
Protein gms/day 63 ± 33 p = 0.013 -20 ± 38 p = 0.244 -21 ± 38 p = 0.276 23 ± 109 p = 0.596 16 ± 75 p = 0.364 0.275
Carbohydrates 
Gms/day
27 ± 104 p = 0.588 -41 ± 49 p = 0.278 -246 ± 314 p = 0.155 -82 ± 104 p = 0.084 -89 ± 193 p = 0.052 0.143
Fats Gms/d -24 ± 29 p = 0.143 -22 ± 16 p = 0.146 -51 ± 68 p = 0.168 -13 ± 28 p = 0.267 -27 ± 41 p = 0.009 0.481
Data are mean ± SD. Significant changes are indicated using an alpha level of p < 0.05.
Mean (± SD) lean body mass measured at baseline and fol- lowing 12 weeks of protein supplementation and resistance  exercise Figure 1
Mean (± SD) lean body mass measured at baseline and fol-
lowing 12 weeks of protein supplementation and resistance 
exercise. At week 12, group analysis shows a significant 
enhancement in lean mass (0.9 kg, p = 0.007). A trend 
towards significance within groups was present only in the 
soy isolate group (p = 0.055).Journal of the International Society of Sports Nutrition 2007, 4:4 http://www.jissn.com/content/4/1/4
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Group serum estradiol was significantly lowers following
supplementation and training (p = 0.002). A significant
within group decrease in the WB intervention was evident
(-9.1 pg/ml, p = 0.033) and although not significant a
trend towards lower values was observed in all other
groups (Figure 6).
Profile of mood states (POMS)
No significant change over the course of the supplementa-
tion period was observed for POMS fatigue within and
across groups. The effects of protein supplementation and
training on POMS vigor over the 12 week period did not
significantly change across groups. However, a significant
decrease in POMS vigor was noted in the SC group (+3.2,
p = 0.040).
Discussion
This study is the first to investigate the effects of whey and
soy protein supplements on androgenic hormones during
12 weeks of resistance training. The main finding was that
12 weeks of resistance training induced similar gains in
lean body mass in subjects consuming a diet supple-
mented with whey or soy protein (Figure 1). This finding
is contrary to the hypothesis that soy is an inferior source
of protein in comparison to whey.
The SI supplemented group neared significance regarding
lean mass increases over the 12 week training schedule
Mean (± SD) of SHBG at baseline and following 12 weeks of  protein supplementation and resistance exercise Figure 5
Mean (± SD) of SHBG at baseline and following 12 weeks of 
protein supplementation and resistance exercise. No signifi-
cant changes between or across groups were evident at 
week 12.
Mean (± SD) of free testosterone at baseline and following  12 weeks of protein supplementation and resistance exercise Figure 3
Mean (± SD) of free testosterone at baseline and following 
12 weeks of protein supplementation and resistance exer-
cise. No significant changes between groups were evident at 
week 12.
Mean (± SD) of total testosterone at baseline and following  12 weeks of protein supplementation and resistance exercise Figure 2
Mean (± SD) of total testosterone at baseline and following 
12 weeks of protein supplementation and resistance exer-
cise. No significant changes between or within groups were 
evident at week 12.
Mean (± SD) of testosterone/estradiol ratio following 12  weeks of protein supplementation and resistance exercise Figure 4
Mean (± SD) of testosterone/estradiol ratio following 12 
weeks of protein supplementation and resistance exercise. 
As significant increase in the testosterone/estradiol ratio 
between groups was noted (+13.4, p = 0.005). The testoster-
one/estradiol ratio within the SW group was higher at week 
12 in comparison to baseline measurements (+16.3, p = 
0.030). * Indicates significant difference (p < 0.05)Journal of the International Society of Sports Nutrition 2007, 4:4 http://www.jissn.com/content/4/1/4
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(Figure 1). Previously, studies over a similar time frame
have shown no significant differences between soy and
whey supplementation with equal protein content [25].
This suggests that over the short term the bioactive com-
position of these proteins has little additive effect on the
magnitude of change in lean tissue mass. However, the
subjects enrolled in the study were relatively novice exer-
cisers with little previous exposure to training program.
This may result in only early stage hypertrophic adapta-
tion [26]. The rationale is that early adaptive response to
resistance exercise is neuromuscular in etiology and sub-
sequent skeletal muscle fiber hypertrophy plays only a
minor part in the total adaptive response [26].
Soy is well known for its estrogenic effects, which may
occur through the hypothalamic-pituitary-gonadal axis
[27]. Isoflavones inhibit key steroidogenic linked
enzymes including aromatase enzyme, 17β-hydroxyster-
oid oxidoreductase and cytochrome p-450 with the latter
responsible for estrogen hydroxylation [28,27,4]. These
postulated mechanisms provide a probable rationale for
the decline in serum estradiol across all soy groups within
the current study (Figure 6). Reduction in serum estrogens
has previously been shown following soy-milk supple-
mentation for 8 weeks [29]. A declining trend in estradiol
was also evident following supplementation in the WB
group, although not statistically significant (Figure 6).
Although it is not clear why whey protein may down-reg-
ulate estrogen synthesis, there may be a link to the activity
of CYP 3A4 [30], or similar estrogen influencing biochem-
ical pathways following whey consumption. The potential
interaction of whey protein and estrogen synthesis is an
area worthy of further study.
As previously discussed, isoflavones may have a signifi-
cant effect on circulating levels of testosterone. To date 11
previous studies have evaluated the effects of isoflavones
and soy on sex hormone levels [31,12,14,17-
19,22,32,33,16,20], of which only two have shown a sig-
nificant decline in testosterone [12,14]. Although the
effects on total testosterone were minor, the relative
response correlated to increasing isoflavone content.
Gardner-Thorpe et al. gave 120 mg of isoflavones per day,
a level comparable to the 138 mg/day supplementation
for the SC group in the current study (Table 2). That the
SC group was the only soy containing group showing a
numerical reduction (not statistically significant) towards
declining testosterone concentrations further suggests that
a future study may want to evaluated if SC in a dose
dependent manner affects serum testosterone levels. The
biologically active and less commonly assessed free testo-
sterone was not significantly reduced across all groups.
Based on mean data, a trend towards a decline in the SC
group was again evident (Figure 3). However, the lack of
significance on circulating free testosterone levels corrob-
orates previous studies on high protein soy isolates and
soy-milk [15,16] but not for milk proteins [34,35] which
may be as a direct result of differences in training method-
ology between studies.
The significant increase in the testosterone/estradiol ratio
further contradicts any suggested relationship with declin-
ing androgenic activity following soy consumption (Fig-
ure 4). Both the biological activity and systemic clearance
are influenced by the binding capacity of SHBG [36-38].
Since SHBG may alter the balance of both bound and
unbound estrogens and androgens and has a greater bind-
ing to testosterone, the lack of effect on serum testoster-
one (free and total) should be reflected in shifts in SHBG
concentrations. In agreement with previous studies on
protein sources of phytoestrogens (i.e. soy), the current
study has shown no significant change (Figure 5)
[14,19,16] in testosterone or SHBG. The lack of significant
changes in SHBG may be due to confounding dietary var-
iables, physical activity, lifestyle factors [39-41], and bod-
yweight [42]. Factors such as diet not controlled in the
present study cannot be discounted. Although dietary
intake (fat and calories) was significantly different
between groups, 24 h dietary recall has significant limita-
tions with regard to precision; nutrient intake estimates
can ranging from 4 to 400% when compared with
observed intakes [43]. However, work comparing 24 hr
Mean (± SD) of estradiol at baseline and following 12 weeks  of protein supplementation and resistance exercise Figure 6
Mean (± SD) of estradiol at baseline and following 12 weeks 
of protein supplementation and resistance exercise. Serum 
estradiol was significantly lower in all four groups following 
supplementation and training (p = 0.002). Within group anal-
ysis shows a significant decrease in the WB intervention was 
statistically significant (-9.1 pg/ml, p = 0.033). * Indicates sig-
nificant difference (p < 0.05)Journal of the International Society of Sports Nutrition 2007, 4:4 http://www.jissn.com/content/4/1/4
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versus 3 day dietary record shows comparable results as
general indicators of dietary intake [44]. Even with the use
of biomarkers dietary analysis can prove inaccurate [44].
As this was a free-living study without controlled diets 24
hr recall was deemed an appropriate indicator of esti-
mated dietary intake patterns, however precise nutrient
intake records maybe considered a limitation of the cur-
rent study. Although a free living based nutritional study
design is efficacious to external validity, the integration of
30-day or multiple 24 hour recall assessment could be
employed to better detect dietary influences on training
and hormonal adaptation.
The resistance training protocol utilized in the present
study effectively increased the accretion of lean tissue irre-
spective of intervention. Increases in lean mass are con-
sistent with the results of previous investigations [45,46].
The application of 12 weeks of resistance training was
based on previous research describing the occurrence of
significant muscle hypertrophy within this time frame
[47,48] and that significant diet-related differences in
muscle hypertrophy occur within this period [47,48]. The
results of the present study confirm these earlier studies
regarding adaptive responses to diet and training.
No consistent effects were evident in the fatigue and vigor
scores, although the POMS-Vigor score increased signifi-
cantly in the highest isoflavone containing group (SC).
Although, previous work has shown improvements in
mood with exercise [49] and mood in females following
isoflavone consumption [50], this is the first study to
show any effect on males.
Conclusion
The current randomized and blinded intervention study
in healthy men demonstrated that protein, irrespective of
source (SI, SC, SW or WB), coupled with resistance train-
ing results in a significant enhancement of lean body
mass. There was no significant decrease in serum andro-
genic hormones following supplementation with any pro-
tein intervention. The biological significance of the sex
hormone changes within the current study resulting from
lower estradiol, and increased testosterone/estradiol ratio
in response to soy and whey supplementation is
unknown at this time. The isoflavone content may affect
the magnitude of hormonal change as may the duration
of dietary exposure to supplemental isoflavones.
This is the first study to report low-level isoflavone con-
tent in commercial whey proteins, and future studies
should take this into consideration when looking to
designing an isoflavone free control study. Previous work
has shown occurrence of isoflavones in the range of 1–30
ng/ml in bovine milk [51] suggesting that whey may not
be an isoflavone free protein source. Although the sex hor-
mone measurements were not statistically different in
comparison to soy, factors such as sample size and dura-
tion of supplementation may have influenced outcome.
Other factors such as equol responders and non-respond-
ers were not addressed in the current study. Because equol
is know to influence the biochemical responses to isofla-
vone containing proteins further study is needed to asses
its impact on lean mass changes [52]. Because both pro-
tein source and bioactive content may bring about specific
biochemical non-hypertrophic responses to exercise; such
as increased antioxidant capacity [25], future work should
look to measure performance markers to detect additional
benefits from dietary protein supplementation. In conclu-
sion, it appears that both soy and whey supplementation
in free living resistance training men results in lean body
mass accretion without negatively affecting serum andro-
gen levels.
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